Apton Biosystems snags $24m Series A

Apton Biosystems Inc, a developer of Super-Res sequencing and single-molecule detection systems for large-scale clinical applications, has raised $24 million in Series A financing.

Apton Biosystems Inc, a developer of Super-Res sequencing and single-molecule detection systems for large-scale clinical applications, has raised $24 million in Series A financing. Kern Capital led the round with participation from other backers that included Casdin Capital and Khosla Ventures.

Source: Press Release